HUP0002905A3 - 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use - Google Patents

2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use

Info

Publication number
HUP0002905A3
HUP0002905A3 HU0002905A HUP0002905A HUP0002905A3 HU P0002905 A3 HUP0002905 A3 HU P0002905A3 HU 0002905 A HU0002905 A HU 0002905A HU P0002905 A HUP0002905 A HU P0002905A HU P0002905 A3 HUP0002905 A3 HU P0002905A3
Authority
HU
Hungary
Prior art keywords
methylimidazol
fluoropyrimidine
piperazinyl
dichloro
butyl
Prior art date
Application number
HU0002905A
Other languages
English (en)
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of HUP0002905A2 publication Critical patent/HUP0002905A2/hu
Publication of HUP0002905A3 publication Critical patent/HUP0002905A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Nutrition Science (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0002905A 1997-06-02 1998-05-28 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use HUP0002905A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9706738A FR2763950B1 (fr) 1997-06-02 1997-06-02 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
PCT/EP1998/003190 WO1998055476A1 (fr) 1997-06-02 1998-05-28 2-{4-[4-(4,5-dichloro-2- methylimidazol-1-yl)butyl] -1-piperazinyl}-5-fluoropyrimidine, sa preparation et son utilisation therapeutique

Publications (2)

Publication Number Publication Date
HUP0002905A2 HUP0002905A2 (hu) 2001-06-28
HUP0002905A3 true HUP0002905A3 (en) 2002-01-28

Family

ID=9507480

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0002905A HUP0002905A3 (en) 1997-06-02 1998-05-28 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use

Country Status (22)

Country Link
US (2) US6303608B1 (hu)
EP (1) EP1007522B1 (hu)
JP (1) JP4344890B2 (hu)
KR (1) KR100556559B1 (hu)
CN (1) CN1094491C (hu)
AT (1) ATE228126T1 (hu)
AU (1) AU732722B2 (hu)
BR (1) BR9810240A (hu)
CA (1) CA2292746A1 (hu)
DE (1) DE69809564T2 (hu)
DK (1) DK1007522T3 (hu)
ES (1) ES2149691B1 (hu)
FR (1) FR2763950B1 (hu)
HU (1) HUP0002905A3 (hu)
IL (1) IL133216A0 (hu)
NO (1) NO318757B1 (hu)
NZ (1) NZ501566A (hu)
PL (1) PL190777B1 (hu)
PT (1) PT1007522E (hu)
RU (1) RU2191184C2 (hu)
TR (1) TR199903001T2 (hu)
WO (1) WO1998055476A1 (hu)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101152658B1 (ko) * 2009-04-30 2012-06-18 한국과학기술연구원 세로토닌 5-ｈｔ6 길항 활성 효과를 갖는 피페라진 화합물 함유 조성물
RU2660583C1 (ru) * 2017-08-15 2018-07-06 Общество С Ограниченной Ответственностью "Валента - Интеллект" Применение буспирона для лечения функционального головокружения

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642759B1 (fr) * 1989-02-09 1991-05-17 Laboratorios Esteve Sa Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2672052B1 (fr) 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2673628B1 (fr) * 1991-03-07 1993-07-09 Esteve Labor Dr Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
FR2712808B1 (fr) * 1993-11-25 1996-02-16 Esteve Labor Dr Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
FR2742052B1 (fr) * 1995-12-12 1998-04-10 Esteve Labor Dr Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports

Also Published As

Publication number Publication date
NZ501566A (en) 2001-06-29
PT1007522E (pt) 2003-04-30
AU732722B2 (en) 2001-04-26
DK1007522T3 (da) 2003-03-17
FR2763950B1 (fr) 2002-09-20
BR9810240A (pt) 2000-09-05
DE69809564D1 (de) 2003-01-02
TR199903001T2 (xx) 2000-07-21
EP1007522B1 (fr) 2002-11-20
NO318757B1 (no) 2005-05-02
KR100556559B1 (ko) 2006-03-06
RU2191184C2 (ru) 2002-10-20
DE69809564T2 (de) 2003-07-10
CN1094491C (zh) 2002-11-20
FR2763950A1 (fr) 1998-12-04
NO995894D0 (no) 1999-12-01
WO1998055476A1 (fr) 1998-12-10
ES2149691B1 (es) 2001-05-16
ATE228126T1 (de) 2002-12-15
ES2149691A1 (es) 2000-11-01
AU7917098A (en) 1998-12-21
IL133216A0 (en) 2001-03-19
KR20010013274A (ko) 2001-02-26
HUP0002905A2 (hu) 2001-06-28
CA2292746A1 (fr) 1998-12-10
PL337113A1 (en) 2000-07-31
PL190777B1 (pl) 2006-01-31
JP4344890B2 (ja) 2009-10-14
JP2002501539A (ja) 2002-01-15
CN1261888A (zh) 2000-08-02
US6346620B1 (en) 2002-02-12
EP1007522A1 (fr) 2000-06-14
US6303608B1 (en) 2001-10-16
NO995894L (no) 2000-02-01

Similar Documents

Publication Publication Date Title
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
ZA989249B (en) Heteroaromatic compounds and their use in medicine.
HUP0004463A3 (en) Fluoropyrazole-biphenylamide fungicides, preparation and use thereof
HK1078561A1 (en) Novel compounds, their use and preparation
IL127132A (en) Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HK1034722A1 (en) Antipicornaviral compounds, their preparation and use
ZA986421B (en) 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use.
HK1019606A1 (en) Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them
HUP0103636A3 (en) 2-methyl-thieno-benzodiazepine formulation and its use
HUP9801256A3 (en) 5'-deoxy-cytidine derivatives, preparation and use thereof and pharmaceutical compositions
SI1043307T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and their use
IL129927A0 (en) 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application
IL113332A0 (en) Boronic peptide derivatives, preparation and therapeutic application thereof
CZ2000522A3 (cs) Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití
HRP20020372A2 (en) N-guanidinoalkylamides, their preparation, their use, and pharmaceutical preparations comprising them
ZA9810625B (en) Benzylidenepyrazolones, their preparation and use.
ZA989571B (en) 2-Substituted 1,2-Benzoisonthiazole derivatives, their preparation and use.
EP1142589A4 (en) MEDICAL COMPOSITIONS
HUP0002905A3 (en) 2-{4-[-(4,5-dichloro-2-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use
IL133536A0 (en) 6-pyrrolidin-2-ylpyridine derivatives, their preparation and application in therapy
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use
SI1043306T1 (en) 3-amino-3-arylpropan-1-ol-derivates, their preparation and use
HUP0203455A3 (en) 2-arylquinoline derivatives, preparation and therautic use thereof
AU1566599A (en) 3-oxazol-5-yl-1-oxo-1,2-dihydroisoquinoline-4-propanamide derivatives, preparation and therapeutic application
HUP9800542A3 (en) Epoxy-azetidinones, preparation and use thereof

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees